Submitted by Anonymous (not verified) on 4 August 2026 - 16:00
Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Revision: 5, Status: Authorised